SPDR S&P Biotech ETF
146 hedge funds and large institutions have $2.16B invested in SPDR S&P Biotech ETF in 2014 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 11 closing their positions.
Holders
146
Holders Change
+17
Holders Change %
+13.18%
% of All Funds
3.9%
Holding in Top 10
7
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+250%
% of All Funds
0.19%
New
33
Increased
49
Reduced
42
Closed
11
Calls
$65.8M
Puts
$137M
Net Calls
-$71.1M
Net Calls Change
-$33.1M
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$221M |
| 2 |
CS
2
Credit Suisse
Zurich,
Switzerland
|
$29.4M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$401M |
| 4 |
4
Goldman Sachs
New York
|
$614M |
| 5 |
5
SG Americas Securities
New York
|
$1.51M |
